Characterization and treatment outcomes of rituximab therapy in super-responders and rituximab-refractory pemphigus patients: A single-center retrospective study

Supplementary Table 1 summarizes the baseline demographic and clinical characteristics of patients categorized into three response groups receiving rituximab. Supplementary Table 2 presents the univariable logistic regression analyses evaluating patient characteristics associated with super-responders compared with non–super-responders. Supplementary Table 3 contains the univariable logistic regression results identifying factors associated with rituximab-refractory pemphigus in comparison to non–refractory patients.